MedPath

RISPERDAL CONSTA, 37,5 mg POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA PARA INYECCION INTRAMUSCULAR

RISPERDAL CONSTA, 37,5 mg POLVO Y DISOLVENTE PARA SUSPENSION DE LIBERACION PROLONGADA PARA INYECCION INTRAMUSCULAR

Commercialized
Register Number

65215

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Feb 10, 2003

Dosage Form

POLVO Y DISOLVENTE PARA SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADA

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number65215
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RISPERIDONAActive
Quantity: 37,5 mg
Name: RISPERIDONA

ATC CLASSIFICATION (3)

N05A
N05AX
N05AX08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.